Gene · 6653
Papers2,220
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,220
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mice and minipigs with compromised expression of the Alzheimer's disease gene SORL1 show cerebral metabolic disturbances on hyperpolarized [1-13C]pyruvate and sodium MRI. | Brain Commun | 2024 | 38650831 | PubTator, text mining | PubMed |
| Limbic-predominant age-related TDP-43 encephalopathy (LATE-NC): Co-pathologies and genetic risk factors provide clues about pathogenesis. | J Neuropathol Exp Neurol | 2024 | 38613823 | PubTator, text mining | PubMed |
| Urine proteome profile of firefighters with exposure to emergency fire-induced smoke: A pilot study to identify potential carcinogenic effects. | Sci Total Environ | 2024 | 38583625 | PubTator, text mining | PubMed |
| Morphological profiling in human neural progenitor cells classifies hits in a pilot drug screen for Alzheimer's disease. | Brain Commun | 2024 | 38576795 | PubTator, text mining | PubMed |
| SorLA restricts TNFα release from microglia to shape a glioma-supportive brain microenvironment. | EMBO Rep | 2024 | 38499808 | PubTator, text mining | PubMed |
| Corrigendum: Sorl1 knockout inhibits expression of brain-derived neurotrophic factor: involvement in the development of late-onset Alzheimer's disease. | Neural Regen Res | 2024 | 38488554 | PubTator, text mining | PubMed |
| Editorial: Insights in RNA: 2022. | Front Genet | 2024 | 38456016 | PubTator, text mining | PubMed |
| Diagnostic Value of sLR11 and sIL-2R in the Cerebrospinal Fluid for Malignant Central Nervous System Lymphoma. | Intern Med | 2024 | 38432983 | PubTator, text mining | PubMed |
| Lessons from genetic studies in Alzheimer disease. | Rev Neurol (Paris) | 2024 | 38429159 | PubTator, text mining | PubMed |
| Differential effects of SORL1 deficiency on the endo-lysosomal network in human neurons and microglia. | Philos Trans R Soc Lond B Biol Sci | 2024 | 38368935 | PubTator, text mining | PubMed |
| Functional characterization of SORL1 variants in cell-based assays to investigate variant pathogenicity. | Philos Trans R Soc Lond B Biol Sci | 2024 | 38368933 | PubTator, text mining | PubMed |
| An in silico approach to identify potential downstream targets of miR-153 involved in Alzheimer's disease. | Front Genet | 2024 | 38299037 | PubTator, text mining | PubMed |
| Assessment of Mendelian and risk-factor genes in Alzheimer disease: A prospective nationwide clinical utility study and recommendations for genetic screening. | Genet Med | 2024 | 38281098 | PubTator, text mining | PubMed |
| Experimental Tumor Induction and Evaluation of Its Treatment in the Chicken Embryo Chorioallantoic Membrane Model: A Systematic Review. | Int J Mol Sci | 2024 | 38255911 | PubTator, text mining | PubMed |
| A familial missense variant in the Alzheimer's disease gene SORL1 impairs its maturation and endosomal sorting. | Acta Neuropathol | 2024 | 38244079 | PubTator, text mining | PubMed |
| Knowledge domains and emerging trends of Genome-wide association studies in Alzheimer's disease: A bibliometric analysis and visualization study from 2002 to 2022. | PLoS One | 2024 | 38241287 | PubTator, text mining | PubMed |
| Microglia as a Possible Alternative Therapeutic for Dementia. | J Alzheimers Dis Rep | 2024 | 38229830 | PubTator, text mining | PubMed |
| SORCS2 activity in pancreatic α-cells safeguards insulin granule formation and release from glucose-stressed β-cells. | iScience | 2024 | 38226160 | PubTator, text mining | PubMed |
Validation of the "Perceptions Regarding pRE-Symptomatic Alzheimer's Disease Screening" (PRE-ADS) Questionnaire in the German Population: Attitudes, Motivations, and Barriers to Pre-Symptomatic Dementia Screening. | J Alzheimers Dis | 2024 | 38189757 | PubTator, text mining | PubMed |
| Current biomarkers and treatment strategies in Alzheimer disease: An overview and future perspectives. | IBRO Neurosci Rep | 2024 | 38169888 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6653/papers?page=7